High blood eosinophil counts predict sputum eosinophilia in patients with severe asthma

Journal of Allergy and Clinical Immunology

Volumn 135, Issue 3, 2015, Pages 822-824.e2

  Fowler, Stephen J ^a,b   Tavernier, Gaël ^a   Niven, Robert ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b LANCASHIRE TEACHING HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE DIPROPIONATE; PREDNISONE; TRIAMCINOLONE; ANTIASTHMATIC AGENT; BECLOMETASONE;

ASTHMA; BLOOD SAMPLING; CORTICOSTEROID THERAPY; EOSINOPHIL COUNT; EOSINOPHILIA; HUMAN; LETTER; MAJOR CLINICAL STUDY; PHENOTYPE; PREDICTIVE VALUE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SPUTUM; CYTOLOGY; DRUG EFFECTS; EOSINOPHIL; IMMUNOLOGY; LEUKOCYTE COUNT; PATHOLOGY; SEVERITY OF ILLNESS INDEX; TH2 CELL;

ANTI-ASTHMATIC AGENTS; ASTHMA; BECLOMETHASONE; EOSINOPHILIA; EOSINOPHILS; HUMANS; LEUKOCYTE COUNT; PREDICTIVE VALUE OF TESTS; PREDNISONE; SEVERITY OF ILLNESS INDEX; SPUTUM; TH2 CELLS; TRIAMCINOLONE;

EID: 84924352683     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2014.09.034     Document Type: Article

References (9)

1. R.H. Green, C.E. Brightling, S. McKenna, B. Hargadon, D. Parker, and P. Bradding Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial Lancet 360 2002 1715 1721
2. P. Nair, M.M. Pizzichini, M. Kjarsgaard, M.D. Inman, A. Efthimiadis, and E. Pizzichini Mepolizumab for prednisone-dependent asthma with sputum eosinophilia N Engl J Med 360 2009 985 993
3. A.T. Hastie, W.C. Moore, H. Li, B.M. Rector, V.E. Ortega, and R.M. Pascual Biomarker surrogates do not accurately predict sputum eosinophil and neutrophil percentages in asthmatic subjects J Allergy Clin Immunol 132 2013 72 80
4. H.K. Reddel, D.R. Taylor, E.D. Bateman, L.P. Boulet, H.A. Boushey, and W.W. Busse An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice Am J Respir Crit Care Med 180 2009 59 99
5. P.C. Fulkerson, and M.E. Rothenberg Targeting eosinophils in allergy, inflammation and beyond Nat Rev Drug Discov 12 2013 117 129
6. E. Pizzichini, M.M. Pizzichini, A. Efthimiadis, F.E. Hargreave, and J. Dolovich Measurement of inflammatory indices in induced sputum: effects of selection of sputum to minimize salivary contamination Eur Respir J 9 1996 1174 1180
7. I.D. Pavord, S. Korn, P. Howarth, E.R. Bleecker, R. Buhl, and O.N. Keene Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial Lancet 380 2012 651 659
8. H.G. Ortega, M.C. Liu, I.D. Pavord, G.G. Brusselle, J.M. FitzGerald, and A. Chetta Mepolizumab treatment in patients with severe eosinophilic asthma N Engl J Med 371 2014 1198 1207
9. P. Flood-Page, C. Swenson, I. Faiferman, J. Matthews, M. Williams, and L. Brannick A study to evaluate safety and efficacy of mepolizumab in patients with moderate persistent asthma Am J Respir Crit Care Med 176 2007 1062 1071